HomeGH • NASDAQ
add
Guardant Health Inc
Previous close
$103.10
Day range
$93.79 - $103.58
Year range
$34.91 - $120.71
Market cap
12.39B USD
Avg Volume
2.05M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 281.27M | 39.37% |
Operating expense | 302.05M | 20.36% |
Net income | -128.49M | -15.75% |
Net profit margin | -45.68 | 16.95% |
Earnings per share | -0.50 | 19.35% |
EBITDA | -110.87M | 4.65% |
Effective tax rate | 1.33% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.20B | 43.05% |
Total assets | 2.01B | 35.54% |
Total liabilities | 2.11B | 30.01% |
Total equity | -99.31M | — |
Shares outstanding | 130.64M | — |
Price to book | -135.66 | — |
Return on assets | -18.28% | — |
Return on capital | -23.54% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -128.49M | -15.75% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
Founded
2012
Headquarters
Website
Employees
2,490
